BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7387728)

  • 1. Generation of carbon monoxide during the microsomal metabolism of methylenedioxyphenyl compounds.
    Yu LS; Wilkinson CF; Anders MW
    Biochem Pharmacol; 1980 Apr; 29(8):1113-22. PubMed ID: 7387728
    [No Abstract]   [Full Text] [Related]  

  • 2. The enzymic formation of methylenedioxyphenyl derivative exhibiting an isocyanide-like spectrum with reduced cytochrome P-450 in hepatic microsomes.
    Franklin MR
    Xenobiotica; 1971 Nov; 1(6):581-91. PubMed ID: 4154538
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-catalysed, O2-independent inactivation of NADPH- or dithionite-reduced microsomal cytochrome P-450 by carbon tetrachloride.
    de Groot H; Haas W
    Biochem Pharmacol; 1981 Aug; 30(16):2343-7. PubMed ID: 7295345
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of synergists on drug metabolism.
    Hodgson E; Philpot RM; Baker RC; Mailman RB
    Drug Metab Dispos; 1973; 1(1):391-401. PubMed ID: 4149410
    [No Abstract]   [Full Text] [Related]  

  • 5. Formation of similar species to carbon monoxide during hepatic microsomal metabolism of cannabidiol on the basis of spectral interaction with cytochrome P-450.
    Watanabe K; Narimatsu S; Gohda H; Yamamoto I; Yoshimura H
    Biochem Pharmacol; 1988 Dec; 37(24):4719-26. PubMed ID: 3202905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperonyl butoxide metabolism by cytochrome P-450: factors affecting the formation and disappearance of the metabolite-cytochrome P-450 complex.
    Franklin MR
    Xenobiotica; 1972 Nov; 2(6):517-27. PubMed ID: 4145693
    [No Abstract]   [Full Text] [Related]  

  • 7. The production and modification of cytochrome P-450 difference spectra by in vivo administration of methylenedioxyphenyl compounds.
    Philpot RM; Hodgson E
    Chem Biol Interact; 1972 Feb; 4(3):185-94. PubMed ID: 5008936
    [No Abstract]   [Full Text] [Related]  

  • 8. Spectral interactions of piperonyl butoxide and isocyanides with purified hepatic cytochrome P-450 from uninduced mice.
    Beumel GA; Levi PE; Hodgson E
    Gen Pharmacol; 1985; 16(3):193-7. PubMed ID: 4018535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reduction of polyhalogenated methanes by liver microsomal cytochrome P450.
    Wolf CR; Mansuy D; Nastainczyk W; Deutschmann G; Ullrich V
    Mol Pharmacol; 1977 Jul; 13(4):698-705. PubMed ID: 18662
    [No Abstract]   [Full Text] [Related]  

  • 10. [Formation of chloroform from carbon tetrachloride in liver microsomes, lipid peroxidation and destruction of cytochrome P-450].
    Reiner O; Athanassopoulos S; Hellmer KH; Murray RE; Uehleke H
    Arch Toxikol; 1972; 29(3):219-33. PubMed ID: 4404917
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of piperonyl butoxide concentration on the formation of cytochrome P-450 difference spectra in hepatic microsomes from mice.
    Philpot RM; Hodgson E
    Mol Pharmacol; 1972 Mar; 8(2):204-14. PubMed ID: 4402004
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of haloforms to carbon monoxide. I. In vitro studies.
    Ahmed AE; Kubic VL; Anders MW
    Drug Metab Dispos; 1977; 5(2):198-204. PubMed ID: 15814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of nitromethane with reduced hepatic microsomal cytochrome P-450.
    Wade AE; Evans JS; Sternson LA; Gammans RE
    Biochem Pharmacol; 1977 May; 26(10):963-7. PubMed ID: 16606
    [No Abstract]   [Full Text] [Related]  

  • 14. Dieldrin metabolism to cis-dihydroaldrindiol and epimerization of cis- to trans-dihydroaldrindiol by rat liver microsomes.
    Matthews HB; McKinney JD
    Drug Metab Dispos; 1974; 2(4):333-40. PubMed ID: 4153314
    [No Abstract]   [Full Text] [Related]  

  • 15. Microsomal metabolism of arylamides by the rat and guinea pig--II. Oxidation of 3-fluorenylacetamide at carbon atom 9. Formation of 3-acetamido-9-fluorenone.
    Kaplan E; Gutmann HR
    Biochem Pharmacol; 1979 May; 28(10):1609-14. PubMed ID: 38792
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro.
    Potter WZ; Davis DC; Mitchell JR; Jollow DJ; Gillette JR; Brodie BB
    J Pharmacol Exp Ther; 1973 Oct; 187(1):203-10. PubMed ID: 4147720
    [No Abstract]   [Full Text] [Related]  

  • 17. Iopronic acid interaction with hepatic microsomal cytochrome P-450: relationship between chemical structure and binding.
    Facino RM; Raffaeli E; Pitré D
    Pharmacol Res Commun; 1979 Feb; 11(2):105-14. PubMed ID: 35794
    [No Abstract]   [Full Text] [Related]  

  • 18. Vinylidene chloride: its metabolism by hepatic microsomal cytochrome P-450 in vitro.
    Costa AK; Ivanetich KM
    Biochem Pharmacol; 1982 Jun; 31(11):2083-92. PubMed ID: 7115426
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450.
    Lettéron P; Fouin-Fortunet H; Tinel M; Danan G; Belghiti J; Pessayre D
    J Pharmacol Exp Ther; 1984 Jun; 229(3):845-50. PubMed ID: 6547179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphasic binding of carbon monoxide with cytochrome P-450 of rat liver microsomes reduced by NADPH.
    Kamataki T; Kitagawa H
    Chem Pharm Bull (Tokyo); 1974 Jan; 22(1):171-5. PubMed ID: 4151551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.